Nolato AB (NOLA B):企業の財務・戦略的SWOT分析

◆英語タイトル:Nolato AB (NOLA B) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1582
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Nolato AB (NOLA B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nolato AB (Nolato) manufactures and markets polymer products and components. The company offers products such as breathing bags, catheter balloons, EMI shielding, thermal management, laboratory products, pharma packaging and protection plugs. It provides mobile phone components including display windows, complete front and back sections, and other specialist components. Nolato offers primary plastic packaging for pharmaceuticals and life-enhancing vitamin and mineral supplements. The company caters to medical technology, pharmaceuticals, telecom, automotive and other sectors. It operates in the UK, Hungary, France, China, India, Malaysia, the Czech Republic, Romania, Germany and others. Nolato is headquartered in Torekov, Sweden.

Nolato AB Key Recent Developments

Feb 10,2020 Nolato Q4 2019: Good performance by all business areas
Oct 23,2019 Nolato Q3 2019: Positive earnings performance by all business areas
May 08,2019 Nolato Q1 2019: Continued strong performance from medical solutions
Feb 12,2019 Nolato year-end report: Strong financial position and proposed increase in dividend

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Nolato AB – Key Facts
Nolato AB – Key Employees
Nolato AB – Key Employee Biographies
Nolato AB – Major Products and Services
Nolato AB – History
Nolato AB – Company Statement
Nolato AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Nolato AB – Business Description
Business Segment: Industrial Solutions
Overview
Performance
Business Segment: Integrated Solutions
Overview
Performance
Business Segment: Medical Solutions
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other Nordic Countries
Performance
Geographical Segment: Rest of Europe
Performance
Geographical Segment: Sweden
Performance
Nolato AB – SWOT Analysis
SWOT Analysis – Overview
Nolato AB – Strengths
Nolato AB – Weaknesses
Nolato AB – Opportunities
Nolato AB – Threats
Nolato AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Feb 10, 2020: Nolato Q4 2019: Good performance by all business areas
Oct 23, 2019: Nolato Q3 2019: Positive earnings performance by all business areas
May 08, 2019: Nolato Q1 2019: Continued strong performance from medical solutions
Feb 12, 2019: Nolato year-end report: Strong financial position and proposed increase in dividend
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Nolato AB, Key Facts
Nolato AB, Key Employees
Nolato AB, Key Employee Biographies
Nolato AB, Major Products and Services
Nolato AB, History
Nolato AB, Subsidiaries
Nolato AB, Key Competitors
Nolato AB, Ratios based on current share price
Nolato AB, Annual Ratios
Nolato AB, Annual Ratios (Cont...1)
Nolato AB, Annual Ratios (Cont...2)
Nolato AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Nolato AB, Performance Chart (2015 - 2019)
Nolato AB, Ratio Charts

★海外企業調査レポート[Nolato AB (NOLA B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SkylineDx BV:企業の製品パイプライン分析
    Summary SkylineDx BV (SkylineDx) is a developer and commercializer of gene signature-based diagnostic tests for personalized medicine in oncology. The company offers MMprofiler and AMLprofiler molecular diagnostic tests for blood cancers. Its AMLprofiler is a vitro diagnostic test that recognizes ac …
  • Tyme Technologies Inc (TYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Tyme Technologies Inc (Tyme) is a clinical-stage pharmaceutical company. The company focused on discovering and developing targeted cancer therapeutics for oncology indications. It develops clinical program SM-88, an oral tyrosine-based therapy that is currently in Phase II development for p …
  • Etam Developpement SCA:企業の戦略・SWOT・財務情報
    Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report Summary Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SSBV-Rovsing A/S:企業の戦略・SWOT・財務情報
    SSBV-Rovsing A/S - Strategy, SWOT and Corporate Finance Report Summary SSBV-Rovsing A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Heidelberger Druckmaschinen AG:企業の戦略・SWOT・財務情報
    Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report Summary Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tata Global Beverages Limited:企業の戦略・SWOT・財務情報
    Tata Global Beverages Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Global Beverages Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Astellas Pharma US Inc-製薬・医療分野:企業M&A・提携分析
    Summary Astellas Pharma US Inc (Astellas Pharma), a subsidiary of Astellas Pharma Inc is a drug company that offers injections and tablets. The company offers products such as adenosine injections, regadenoson injection, tacrolimus ointment, tacrolimus extended-release capsules, tacrolimus capsules …
  • Noble Mineral Exploration Inc (NOB):企業の財務・戦略的SWOT分析
    Summary Noble Mineral Exploration Inc (Noble Mineral) is a mining and mineral exploration and development company that offers mineral resources. The company offers acquisition, exploration mining, production, and development of gold, nickel, copper, zinc, uranium, and mineral resources deposit prope …
  • Carrizo Oil & Gas, Inc. (CRZO)-石油・ガス分野:企業M&A・提携分析
    Summary Carrizo Oil & Gas, Inc. (Carrizo) is an independent oil and gas company, which carries out exploration, development and production of oil and natural gas from several resources plays. It has presence in the Marcellus Shale in Pennsylvania, the Eagle Ford Shale in South Texas, the Niobrara Fo …
  • Thornton & Ross Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products compris …
  • China Banking Corporation:企業の戦略・SWOT・財務情報
    China Banking Corporation - Strategy, SWOT and Corporate Finance Report Summary China Banking Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Lipocine Inc (LPCN):企業の財務・戦略的SWOT分析
    Summary Lipocine Inc (Lipocine) operates as a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testoster …
  • Vietnam Electricity Construction Joint – Stock Corp (VNE):電力:M&Aディール及び事業提携情報
    Summary Vietnam Electricity Construction Joint - Stock Corp (VNECO) is a diversified company. The company operates through its business divisions such as electricity construction, industrial production, delivery of equipment, investment power, and consulting services. Its electricity construction di …
  • Amplia Therapeutics Ltd (ATX):製薬・医療:M&Aディール及び事業提携情報
    Summary Amplia Therapeutics Ltd (Amplia Therapeutics), formerly Innate Therapeutics Ltd, is a pharmaceutical company with focus on the development of focal adhesion kinase (FAK) inhibitors for the treatment of cancer and fibrosis. Its lead drug candidate, AMP945, is a small molecule targeting focal …
  • Magma Fincorp Limited:企業のM&A・事業提携・投資動向
    Magma Fincorp Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Magma Fincorp Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Senzime AB (SEZI):企業の財務・戦略的SWOT分析
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …
  • Kellogg Co:戦略・SWOT・企業財務分析
    Kellogg Co - Strategy, SWOT and Corporate Finance Report Summary Kellogg Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bioorganic Research and Services SA (BNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioorganic Research and Services SA (Bionaturis) is a biotechnology company that develops non-prescription products for production animals and pets. The company offers products such as BNT006, BNT007, BNT010, BNT015 and BNT005. It provides non-therapeutic and therapeutic products for poultry …
  • Direct Conversion AB:企業の戦略的SWOT分析
    Direct Conversion AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • KYORIN Holdings Inc (4569):企業の財務・戦略的SWOT分析
    KYORIN Holdings Inc (4569) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆